|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 4
Zeitschriftenartikel
Mir, Farheen; Mattiello, Federico; Grigg, Andrew; Herold, Michael; Hiddemann, Wolfgang; Marcus, Robert; Seymour, John F.; Bolen, Christopher R.; Knapp, Andrea; Nielsen, Tina und Casulo, Carla
(2020):
Follicular Lymphoma Evaluation Index (FLEX): A new clinical prognostic model that is superior to existing risk scores for predicting progression-free survival and early treatment failure after frontline immunochemotherapy.
In: American Journal of Hematology, Bd. 95, Nr. 12: S. 1503-1510
Seymour, John F.; Marcus, Robert; Davies, Andrew; Gallop-Evans, Eve; Grigg, Andrew; Haynes, Andrew; Herold, Michael; Illmer, Thomas; Nilsson-Ehle, Herman; Soekler, Martin; Duenzinger, Ulrich; Nielsen, Tina; Launonen, Aino und Hiddemann, Wolfgang
(2019):
Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression.
In: Haematologica, Bd. 104, Nr. 6: S. 1202-1208
Cornely, Oliver A.; Robertson, Michael N.; Haider, Shariq; Grigg, Andrew; Geddes, Michelle; Aoun, Mickael; Heinz, Werner J.; Raad, Issam; Schanz, Urs; Meyer, Ralf G.; Hammond, Sarah P.; Mullane, Kathleen M.; Ostermann, Helmut; Ullmann, Andrew J.; Zimmerli, Stefan; Iersel, M. L. P. S. van; Hepler, Deborah A.; Waskin, Hetty; Kartsonis, Nicholas A. und Märtens, Johan
(2017):
Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease.
In: Journal of Antimicrobial Chemotherapy, Bd. 72, Nr. 12: S. 3406-3413
Grigg, Andrew; Dyer, Martin J. S.; Gonzalez Diaz, Marcos; Dreyling, Martin; Rule, Simon; Lei, Guiyuan; Knapp, Andrea; Wassner-Fritsch, Elisabeth und Marlton, Paula
(2017):
Safety and efficacy of obinutuzumab with CHOP or bendamustine in previously untreated follicular lymphoma.
In: Haematologica, Bd. 102, Nr. 4: S. 765-772